banks digital Top Overview

Indian Minister of Steel: Considering the growth of domestic consumption, there is no possibility of assets stranded in the future.There are 695 listed companies in Jiangsu Province. According to the latest statistics of Jiangsu Listed Companies Association, there were 695 listed companies in Jiangsu Province by the end of November, including 15 new companies this year. Among the 695 companies, there are 216 main boards of Shanghai Stock Exchange, 110 in science and technology innovation board, 126 main boards of Shenzhen Stock Exchange (including one pure B-share), 196 Growth Enterprise Market and 47 North Stock Exchange. By geographical distribution, the total number of listed companies in Suzhou is far ahead in the province, reaching 219, 124 in Nanjing, 123 in Wuxi and 72 in Changzhou. In terms of A-shares, as of the end of November, there were 694 A-share listed companies in Jiangsu Province with a total market value of 6,745.231 billion yuan, accounting for 12.92% and 7.80% of the corresponding total of A-share listed companies respectively.Real estate stocks are active again and again. Huayuan Real Estate and Qixia Construction both have daily limit, while Huayuan Real Estate, Qixia Construction, Xinhualian and Xinhuangpu have daily limit, while Suzhou Gaoxin, China Wuyi and Shahe shares have followed suit.

It is reported that the price of iPhone 18 Pro's further use of TSMC's 2nm chip will increase by 70%. It is reported that in 2026, the A20 Pro processor of iPhone 18 Pro will be produced by TSMC's 2 nm process for the first time, and the chip price will rise from the current 50 US dollars to 85 US dollars, with an increase of 70%. With the high cost, the price of iPhone 18 Pro may increase. (Taiwan Province Business Times)Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963)."39 people were pardoned and nearly 1,500 people were commuted", White House: Biden announced "the largest single-day commutation action in modern history", CBS, NBC and other media reported that the White House issued a statement on the 12th local time, saying that US President Biden announced that he would pardon 39 Americans convicted of non-violent crimes and commute the sentences of nearly 1,500 people who were released at home during the COVID-19 epidemic. According to the White House statement, this move represents "the largest single-day commutation action in modern history" in the United States. According to the statement, Biden said that he will take more relevant measures in the next few weeks and will continue to review petitions for pardon and commutation. (World Wide Web)

Zhongzhiwei Technology completed tens of millions of yuan financing. On December 12th, Nanjing Zhongzhiwei Information Technology Co., Ltd. (Zhongzhiwei Technology) completed tens of millions of yuan B1 financing, which was jointly invested by Guangzhou Baiyun Financial Holding Group Co., Ltd. and Beijing Hongfeng Private Equity Fund Management Co., Ltd. This round of financing funds will be used for iterative application of AI+ network security products, breakthrough in key industry landing scenarios and market channel construction. Zhongzhiwei Technology is a solution provider of "city-level data+digital security operation", and has launched a series of new platform-based network security products around AISecOps (artificial intelligence security operation).Dongyang Guangyao submitted a prospectus to be listed in Hong Kong by way of introduction. On December 11th, Dongyangguang Pharmaceutical, the controlling shareholder of Dongyangguang Changjiang Pharmaceutical, submitted a prospectus to the Hong Kong Stock Exchange to be listed in Hong Kong by way of introduction, and the exclusive sponsor was CICC.European Central Bank: It is estimated that the GDP growth rate will be 0.7% in 2024, 1.1% in 2025, 1.4% in 2026 and 1.3% in 2027. (It is expected to be 0.8%, 1.3% and 1.5% respectively in September) It is estimated that the core inflation rate will be 2.9% in 2024, 2.3% in 2025 and 1.9% in 2026. (It is expected to be 2.8%, 2.3% and 2.0% respectively in September) It is estimated that the core inflation rate will be 1.9% in 2027.